Stevens Johnson syndrome in association with Mycoplasma pneumonia

Area of Science:

• Pediatrics
• Infectious Diseases
• Dermatology

Background:

• Stevens Johnson syndrome (SJS) is a severe mucocutaneous reaction.
• Infections like Mycoplasma pneumoniae and HSV are common triggers in children in developed nations.
• Drug triggers are more prevalent in the Indian subcontinent.

Observation:

• A 5-year-old girl presented with Stevens Johnson syndrome.
• The SJS was associated with Mycoplasma pneumoniae infection.
• The patient received intravenous immunoglobulin (IvIg) therapy.

Findings:

• The patient recovered successfully following IvIg treatment.
• This case highlights Mycoplasma pneumoniae as a potential SJS trigger in pediatric patients.
• Intravenous immunoglobulin (IvIg) demonstrated therapeutic efficacy.

Implications:

• Intravenous immunoglobulin (IvIg) may be a viable alternative to glucocorticoids for SJS treatment.
• Early diagnosis and prompt treatment are crucial for favorable outcomes in pediatric SJS.
• Further research into IvIg's role in managing infectious-precipitated SJS is warranted.